Publication | Closed Access

A synthetic approach and molecular docking study of hybrids of quinazolin-4-ones and thiazolidin-4-ones as anticancer agents

Combinatorial ChemistryMedicinal ChemistryBioorganic ChemistryBiochemistryMedicineNatural SciencesPharmacologySynthetic ApproachAnticancer AgentsDrug DevelopmentMolecular DockingMolecular Docking StudyDrug Discovery